IL-10 receptor signaling is essential for TR1 cell function in vivo

Journal of Immunology

Volumn 198, Issue 3, 2017, Pages 1130-1141

  Brockmann, Leonie ^a   Gagliani, Nicola ^a   Steglich, Babett ^a   Giannou, Anastasios D ^a   Kempski, Jan ^a   Pelczar, Penelope ^a   Geffken, Maria ^a   Mfarrej, Bechara ^b   Huber, Francis ^a   Herkel, Johannes ^a   Wan, Yisong Y ^c   Esplugues, Enric ^d   Battaglia, Manuela ^c   Krebs, Christian F ^a   Flavell, Richard A ^d,e   Huber, Samuel ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE P38; RED FLUORESCENT PROTEIN; TRANSCRIPTION FACTOR FOXP3; INTERLEUKIN 10 RECEPTOR; STAT3 PROTEIN; STAT3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CD4+ T LYMPHOCYTE; CD4+ T REGULATORY TYPE 1 CELL; CELL MATURATION; CELL THERAPY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY BOWEL DISEASE; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PROTEIN DEFECT; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TH17 CELL;

ANIMALS; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN-10; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 85014699932     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601045     Document Type: Conference Paper

References (69)

1. Glocker, E.-O., N. Frede, M. Perro, N. Sebire, M. Elawad, N. Shah, and B. Grimbacher. 2010. Infant colitis-it's in the genes. Lancet 376: 1272.
2. Glocker, E. O., D. Kotlarz, K. Boztug, E. M. Gertz, A. A. Schäffer, F. Noyan, M. Perro, J. Diestelhorst, A. Allroth, D. Murugan, et al. 2009. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361: 2033-2045.
3. Kühn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
4. Spencer, S. D., F. Di Marco, J. Hooley, S. Pitts-Meek, M. Bauer, A. M. Ryan, B. Sordat, V. C. Gibbs, and M. Aguet. 1998. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J. Exp. Med. 187: 571-578.
5. Pot, C., L. Apetoh, and V. K. Kuchroo. 2011. Type 1 regulatory T cells (Tr1) in autoimmunity. Semin. Immunol. 23: 202-208.
6. Cong, Y., C. T. Weaver, A. Lazenby, and C. O. Elson. 2002. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. 169: 6112-6119.
7. +) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J. Exp. Med. 195: 603-616.
8. Gagliani, N., T. Jofra, A. Stabilini, A. Valle, M. Atkinson, M. G. Roncarolo, and M. Battaglia. 2010. Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant. Diabetes 59: 433-439.
9. Gagliani, N., S. Gregori, T. Jofra, A. Valle, A. Stabilini, D. M. Rothstein, M. Atkinson, M. G. Roncarolo, and M. Battaglia. 2011. Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation. PLoS One 6: e28434.
10. Clemente-Casares, X., J. Blanco, P. Ambalavanan, J. Yamanouchi, S. Singha, C. Fandos, S. Tsai, J. Wang, N. Garabatos, C. Izquierdo, et al. 2016. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530: 434-440.
11. Bacchetta, R., B. Lucarelli, C. Sartirana, S. Gregori, M. T. Lupo Stanghellini, P. Miqueu, S. Tomiuk, M. Hernandez-Fuentes, M. E. Gianolini, R. Greco, et al. 2014. Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T cells. Front. Immunol. DOI: 10.3389/fimmu.2014.00016.
12. Hippen, K. L., J. L. Riley, C. H. June, and B. R. Blazar. 2011. Clinical perspectives for regulatory T cells in transplantation tolerance. Semin. Immunol. 23: 462-468.
13. Desreumaux, P., A. Foussat, M. Allez, L. Beaugerie, X. Hebuterne, Y. Bouhnik, M. Nachury, V. Brun, H. Bastian, N. Belmonte, et al. 2012. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology 143: 1207-1217.e1201-1202.
14. Roncarolo, M. G., S. Gregori, B. Lucarelli, F. Ciceri, and R. Bacchetta. 2011. Clinical tolerance in allogeneic hematopoietic stem cell transplantation. Immunol. Rev. 241: 145-163.
15. + regulatory T cells controlled by the transcription factor Egr-2. Proc. Natl. Acad. Sci. USA 106: 13974-13979.
16. Magnani, C. F., G. Alberigo, R. Bacchetta, G. Serafini, M. Andreani, M. G. Roncarolo, and S. Gregori. 2011. Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells. Eur. J. Immunol. 41: 1652-1662.
17. Roncarolo, M. G., R. Bacchetta, C. Bordignon, S. Narula, and M. K. Levings. 2001. Type 1 T regulatory cells. Immunol. Rev. 182: 68-79.
18. - precursor cells in the absence of interleukin 10. Nat. Immunol. 8: 931-941.
19. Batten, M., N. M. Kljavin, J. Li, M. J. Walter, F. J. de Sauvage, and N. Ghilardi. 2008. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J. Immunol. 180: 2752-2756.
20. + T cells. Eur. J. Immunol. 43: 1063-1073.
21. Apetoh, L., F. J. Quintana, C. Pot, N. Joller, S. Xiao, D. Kumar, E. J. Burns, D. H. Sherr, H. L. Weiner, and V. K. Kuchroo. 2010. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11: 854-861.
22. Zhu, C., K. Sakuishi, S. Xiao, Z. Sun, S. Zaghouani, G. Gu, C. Wang, D. J. Tan, C. Wu, M. Rangachari, et al. 2015. An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction. [Published erratum appears in 2015 Nat. Commun. DOI: 10.1038/ncomms8657.] Nat. Commun. DOI: 10.1038/ncomms7072.
23. + T cells by inducing Blimp1. Nat. Commun. DOI: 10.1038/ncomms4770.
24. Gagliani, N., M. C. Amezcua Vesely, A. Iseppon, L. Brockmann, H. Xu, N. W. Palm, M. R. de Zoete, P. Licona-Limón, R. S. Paiva, T. Ching, et al. 2015. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523: 221-225.
25. Mascanfroni, I. D., M. C. Takenaka, A. Yeste, B. Patel, Y. Wu, J. E. Kenison, S. Siddiqui, A. S. Basso, L. E. Otterbein, D. M. Pardoll, et al. 2015. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α. Nat. Med. 21: 638-646.
26. + T cells in an interleukin-10-dependent manner. Immunity 34: 554-565.
27. Gagliani, N., T. Jofra, A. Valle, A. Stabilini, C. Morsiani, S. Gregori, S. Deng, D. M. Rothstein, M. Atkinson, M. Kamanaka, et al. 2013. Transplant tolerance to pancreatic islets is initiated in the graft and sustained in the spleen. Am. J. Transplant. 13: 1963-1975.
28. Fitzgerald, D. C., G. X. Zhang, M. El-Behi, Z. Fonseca-Kelly, H. Li, S. Yu, C. J. Saris, B. Gran, B. Ciric, and A. Rostami. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8: 1372-1379.
29. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
30. Himmel, M. E., Y. Yao, P. C. Orban, T. S. Steiner, and M. K. Levings. 2012. Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers. Immunology 136: 115-122.
31. Trzonkowski, P., R. Bacchetta, M. Battaglia, D. Berglund, H. R. Bohnenkamp, A. ten Brinke, A. Bushell, N. Cools, E. K. Geissler, S. Gregori, et al. 2015. Hurdles in therapy with regulatory T cells. Sci. Transl. Med. 7: 304ps18.
32. Chaudhry, A., R. M. Samstein, P. Treuting, Y. Liang, M. C. Pils, J. M. Heinrich, R. S. Jack, F. T. Wunderlich, J. C. Brüning, W. Müller, and A. Y. Rudensky. 2011. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34: 566-578.
33. Weber-Nordt, R. M., J. K. Riley, A. C. Greenlund, K. W. Moore, J. E. Darnell, and R. D. Schreiber. 1996. Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J. Biol. Chem. 271: 27954-27961.
34. Günzl, P., K. Bauer, E. Hainzl, U. Matt, B. Dillinger, B. Mahr, S. Knapp, B. R. Binder, and G. Schabbauer. 2010. Anti-inflammatory properties of the PI3K pathway are mediated by IL-10/DUSP regulation. J. Leukoc. Biol. 88: 1259-1269.
35. Lee, M. S., and Y. J. Kim. 2007. Signaling pathways downstream of patternrecognition receptors and their cross talk. Annu. Rev. Biochem. 76: 447-480.
36. Kamanaka, M., S. T. Kim, Y. Y. Wan, F. S. Sutterwala, M. Lara-Tejero, J. E. Galán, E. Harhaj, and R. A. Flavell. 2006. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25: 941-952.
37. lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology. J. Exp. Med. 208: 1027-1040.
38. Wan, Y. Y., and R. A. Flavell. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102: 5126-5131.
39. H17 cells occurs in the small intestine. Nature 475: 514-518.
40. Becker, C., M. C. Fantini, and M. F. Neurath. 2006. High resolution colonoscopy in live mice. Nat. Protoc. 1: 2900-2904.
41. O'Connor, W., Jr., M. Kamanaka, C. J. Booth, T. Town, S. Nakae, Y. Iwakura, J. K. Kolls, and R. A. Flavell. 2009. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 10: 603-609.
42. Gregori, S., D. Tomasoni, V. Pacciani, M. Scirpoli, M. Battaglia, C. F. Magnani, E. Hauben, and M. G. Roncarolo. 2010. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 116: 935-944.
43. Gorenshteyn, D., E. Zaslavsky, M. Fribourg, C. Y. Park, A. K. Wong, A. Tadych, B. M. Hartmann, R. A. Albrecht, A. García-Sastre, S. H. Kleinstein, et al. 2015. Interactive big data resource to elucidate human immune pathways and diseases. Immunity 43: 605-614.
44. Eden, E., R. Navon, I. Steinfeld, D. Lipson, and Z. Yakhini. 2009. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10: 48.
45. O'Shea, J. J., and P. J. Murray. 2008. Cytokine signaling modules in inflammatory responses. Immunity 28: 477-487.
46. Pot, C., H. Jin, A. Awasthi, S. M. Liu, C. Y. Lai, R. Madan, A. H. Sharpe, C. L. Karp, S. C. Miaw, I. C. Ho, and V. K. Kuchroo. 2009. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183: 797-801.
47. Murai, M., O. Turovskaya, G. Kim, R. Madan, C. L. Karp, H. Cheroutre, and M. Kronenberg. 2009. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat. Immunol. 10: 1178-1184.
48. Stumhofer, J. S., J. S. Silver, A. Laurence, P. M. Porrett, T. H. Harris, L. A. Turka, M. Ernst, C. J. Saris, J. J. O'Shea, and C. A. Hunter. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8: 1363-1371.
49. H17 responses in a Stat3-dependent manner. Science 326: 986-991.
50. Adler, H. S., S. Kubsch, E. Graulich, S. Ludwig, J. Knop, and K. Steinbrink. 2007. Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells. Blood 109: 4351-4359.
51. Dobreva, Z. G., L. D. Miteva, and S. A. Stanilova. 2009. The inhibition of JNK and p38 MAPKs downregulates IL-10 and differentially affects c-Jun gene expression in human monocytes. Immunopharmacol. Immunotoxicol. 31: 195-201.
52. Horie, K., M. Ohashi, Y. Satoh, and T. Sairenji. 2007. The role of p38 mitogenactivated protein kinase in regulating interleukin-10 gene expression in Burkitt's lymphoma cell lines. Microbiol. Immunol. 51: 149-161.
53. Ma, W., W. Lim, K. Gee, S. Aucoin, D. Nandan, M. Kozlowski, F. Diaz-Mitoma, and A. Kumar. 2001. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 276: 13664-13674 (PubMed).
54. Chang, H. D., C. Helbig, L. Tykocinski, S. Kreher, J. Koeck, U. Niesner, and A. Radbruch. 2007. Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3. Eur. J. Immunol. 37: 807-817.
55. Saraiva, M., J. R. Christensen, M. Veldhoen, T. L. Murphy, K. M. Murphy, and A. O'Garra. 2009. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 31: 209-219.
56. Xu, J., Y. Yang, G. Qiu, G. Lal, Z. Wu, D. E. Levy, J. C. Ochando, J. S. Bromberg, and Y. Ding. 2009. c-Maf regulates IL-10 expression during Th17 polarization. J. Immunol. 182: 6226-6236.
57. - T cells into iTreg. PLoS One 3: e3302.
58. Kumar, S., M. S. Jiang, J. L. Adams, and J. C. Lee. 1999. Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogenactivated protein kinase. Biochem. Biophys. Res. Commun. 263: 825-831.
59. H)17 cells by IL-27. Semin. Immunol. 23: 438-445.
60. + T cells via the phosphorylation of STAT1 and STAT3. Immunol. Lett. 136: 21-28.
61. + T-regulatory cells: toward therapy for human diseases. Immunol. Rev. 223: 391-421.
62. Bacchetta, R., S. Gregori, G. Serafini, C. Sartirana, U. Schulz, E. Zino, S. Tomiuk, U. Jansen, M. Ponzoni, C. T. Paties, et al. 2010. Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy. Haematologica 95: 2134-2143.
63. + T regulatory cell-based therapy. Front. Immunol. 6: 593.
64. Battaglia, M., A. Stabilini, E. Draghici, S. Gregori, C. Mocchetti, E. Bonifacio, and M. G. Roncarolo. 2006. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 55: 40-49.
65. Levings, M. K., R. Sangregorio, F. Galbiati, S. Squadrone, R. de Waal Malefyt, and M. G. Roncarolo. 2001. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166: 5530-5539.
66. Akdis, M., J. Verhagen, A. Taylor, F. Karamloo, C. Karagiannidis, R. Crameri, S. Thunberg, G. Deniz, R. Valenta, H. Fiebig, et al. 2004. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199: 1567-1575.
67. Roncarolo, M. G., S. Gregori, R. Bacchetta, and M. Battaglia. 2014. Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. Curr. Top. Microbiol. Immunol. 380: 39-68 (PubMed).
68. Lee, T. S., and L. Y. Chau. 2002. Heme oxygenase-1 mediates the antiinflammatory effect of interleukin-10 in mice. Nat. Med. 8: 240-246.
69. Hossain, D. M., A. K. Panda, A. Manna, S. Mohanty, P. Bhattacharjee, S. Bhattacharyya, T. Saha, S. Chakraborty, R. K. Kar, T. Das, et al. 2013. FoxP3 acts as a cotranscription factor with STAT3 in tumor-induced regulatory T cells. Immunity 39: 1057-1069.